Inova Cardiogenic Shock Registry (INOVA SHOCK)
ConditionCardiogenic Shock
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorInova Health Care Services
About this trial
To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates.
To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017.
To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella).
• Assess survival at three time points.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Cardiogenic Shock team activation
Procedure/SurgeryAny patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute by the designated Cardiogenic Shock Team.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Retrospective review of Cardiogenic shock patients outcomes
To create an archive of retrospective clinical outcomes (acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock) and compare current versus historical survival rates.
Time frame
1 YearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov